The world's scientific and social network for malaria professionals
8489 malaria professionals are enjoying the free benefits of MalariaWorld today

MESA Alliance's blog

Malaria Eradication Scientific Alliance

October 11, 2013 - 09:38 -- MESA Alliance
Tags: 

MESA (the Malaria Eradication Scientific Alliance) follows-up on the malERA agenda and provides a dedicated platform for the community in order to accelerate the translation of the science of malaria eradication for impact.
 

With the community, MESA monitors progress and takes the next steps to advance the science of malaria eradication. MESA reviews existing evidence and supports projects on research questions critical to malaria eradication. For more information, please visit www.mesamalaria.org.

Read MESA's latest posts here.

Webinar 'Evaluating antimalarial safety' from ACT consortium, Oct 7th 2014

September 30, 2014 - 14:07 -- MESA Alliance

Clinical trials are not suitable to identify rare, potentially serious adverse effects of drugs, or to define their safety in high risk populations.

Artemisinin-based combination therapies (or ACTs) are considered safe, but there are concerns over their potential to cause damage to parts of the brain. There is also a concern about their safety in patients infected with HIV. 

YouTube film Science to accelerate us to malaria eradication

July 17, 2014 - 19:30 -- MESA Alliance
A great new science lecture is available on the MESA YouTube channel: 'Science to accelerate us to malaria eradication',  presented by Lee Hall at the Keystone Symposium 2014.
 
Lee presents some key concepts on the vibrant biomedical R&D agenda which we need to support progress towards global malaria eradication. In his lecture, he poses the question of how the changing epidemiology of malaria impacts on research and interventions and highlights five challenges:
 

Review of 'what works' in elimination advocacy

June 19, 2014 - 18:55 -- MESA Alliance
Malaria Journal publishes an Open Access timely review of 'what works' in elimination advocacy. The authors identify 7 key advocacy elements for disease elimination:
 
  1. A global elimination plan, supported by international health bodies.
  2. Thorough costings and tools to support the business case.
  3. An approach that is positioned within a development framework.
  4. Core elimination advocacy messages.
  5. Provision of advocacy tools for partners.
  6. Extensive and effective community engagement.
  7. Strong partnerships

Publication: Planning meeting for operational research on malaria elimination. WHO Meeting report May 2014

June 2, 2014 - 15:50 -- MESA Alliance

Number of pages: 9
Publication date: 2014
Languages: English
WHO reference number: WHO/HTM/ GMP/2014.5

Main objectives: reviewing the malaria operational research landscape; identifying operational challenges, bottlenecks and priority research questions in the transition from malaria control towards elimination; and reaching agreement among the meeting participants on the next steps, roles and responsibilities.

New publications from WHO GMP

May 13, 2014 - 08:30 -- MESA Alliance
Tags: 
Safety review of 8-aminoquinoline antimalarial medicines
 
Written by external authors, this document reviews published and unpublished studies about the safety of primaquine and its precursors, with particular attention to haemolytic anaemia in G6PD-deficient individuals. The study was prepared for and discussed at a 2012 meeting of the WHO evidence review group on the safety and effectiveness of single-dose primaquine as a P. falciparum gametocytocide.
 
Elimination scenario planning
 
WHO has published a manual to help malaria-endemic countries to assess the feasibility of moving towards elimination. The new guide provides a comprehensive framework to assess different scenarios and timelines for reducing the disease burden and moving towards elimination, depending on programme coverage and funding availability.

Pages

Subscribe to RSS - MESA Alliance's blog